Proteotoxicity to Inflammation & Dementia

This feed focuses on the contribution of aging-associated proteotoxicity to inflammation and neurodegenerative disorders, including Alzheimer’s and dementia. Discover the latest research here.

September 13, 2020

The inflammatory response of the supraspinatus muscle in rotator cuff tear conditions

Journal of Shoulder and Elbow Surgery
Lars Henrik FrichKate Lykke Lambertsen
September 10, 2020
Review
Open Access

Proteostasis and Proteotoxicity in the Network Medicine Era

International Journal of Molecular Sciences
Marta LualdiMauro Fasano
September 21, 2020

Menthol in electronic cigarettes: A contributor to respiratory disease?

Toxicology and Applied Pharmacology
Vijayalekshmi NairPrue Talbot
September 15, 2020

Serum proteome assessment in nonalcoholic fatty liver disease in children: a preliminary study

Expert Review of Proteomics
Paweł MałeckiAnna Mania
September 15, 2020

Vitexin prevents Aβ proteotoxicity in transgenic Caenorhabditis elegans model of Alzheimer's disease by modulating unfolded protein response

Journal of Biochemical and Molecular Toxicology
Dicson Sheeja MalarKasi Pandima Devi
September 11, 2020

Proteomic analysis of soluble protein extract of adult Toxocara cati

Comparative Immunology, Microbiology and Infectious Diseases
Nooshin Mehra SoleymanHassan Borji
September 18, 2020

Free Thiol β2-GPI (β-2-Glycoprotein-I) Provides a Link Between Inflammation and Oxidative Stress in Atherosclerotic Coronary Artery Disease

Arteriosclerosis, Thrombosis, and Vascular Biology
James C WeaverSteven A Krilis
September 10, 2020
Open Access

The Molecular Floodgates of Stress-Induced Senescence Reveal Translation, Signalling and Protein Activity Central to the Post-Mortem Proteome

International Journal of Molecular Sciences
Valerie C WasingerHsiao Mei Goh
September 19, 2020

H3 relaxin protects against calcium oxalate crystal-induced renal inflammatory pyroptosis

Cell Proliferation
Jiannan LiuRuihua An
September 18, 2020

A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry-based Glycoproteomics

Molecular & Cellular Proteomics : MCP
Nicholas M RileySharon J Pitteri
September 18, 2020

Integrated glycoproteomics identifies a role of N -glycosylation and galectin-1 on myogenesis and muscle development

Molecular & Cellular Proteomics : MCP
Ronnie BlazevBenjamin L Parker
September 17, 2020
Open Access

Proteomic Profiles of Exosomes of Septic Patients Presenting to the Emergency Department Compared to Healthy Controls

Journal of Clinical Medicine
Daniel C MorrisEmanuel P Rivers
September 18, 2020

Developments in Mass Spectrometry for Glycosaminoglycan Analysis: A Review

Molecular & Cellular Proteomics : MCP
Lauren E PepiI Jonathan Amster
September 18, 2020

Multi-omic comparison of Alzheimer's variants in human ESC-derived microglia reveals convergence at APOE

The Journal of Experimental Medicine
Tongfei LiuHuaxi Xu
September 17, 2020

Proteomics analysis of lung reveals inflammation and cell death induced by atmospheric H2S exposure in pig

Environmental Research
Zhen LiuMartine Schroyen
September 11, 2020
Review

Alzheimer's disease and type 2 diabetes mellitus: a systematic review of proteomic studies

Journal of Neurochemistry
Jessica Diniz PereiraKarina Braga Gomes
September 10, 2020
Review
Open Access

The Challenges of OSCC Diagnosis: Salivary Cytokines as Potential Biomarkers

Journal of Clinical Medicine
Alexandra RoiLaura-Cristina Rusu

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/proteotoxicity-to-inflammation/8cd199f0-9399-4f64-a09e-15887846f7cd